TGF-beta 1, 2, 3 Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 143 publications

Catalog Number	Mfr. No.	Quantity
MAB1835SP	R&D Systems MAB1835SP	25 μg
MAB1835100	R&D Systems MAB1835100	100 μg
MAB1835500	R&D Systems MAB1835500	500 μg

Description

TGF beta 1/2/3 Monoclonal specifically detects TGF beta 1/2/3 in Multi-Species samples. It is validated for Western Blot, Binding Inhibition, Neutralization, ELISA Capture (Matched Antibody Pair).

Specifications

• Antigen: TGF beta 1/2/3
• Dilution: Western Blot 1 μg/mL, Binding Inhibition, Neutralization 0.25-1.25 μg/mL, ELISA Capture (Matched Antibody Pair) 2-8 μg/mL
• Classification: Monoclonal
• Host Species: Mouse
• Target Species: Multi-species
• Gene Alias: ARVD1, CED, DPD1, LAP, LDS5, RNHF, TGF beta1, TGFB, TGFB1, TGFB2, TGFB3, TGFbeta, TGFbeta 1, TGFbeta 2, TGFbeta 3, transforming growth factor, beta 1
• Gene Symbols: TGFB1
• Isotype: IgG1
• Purification Method: Protein A or G purified from hybridoma culture supernatant
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

• Clone: 1D11
• Applications: Western Blot, In vitro Assay, Neutralization, ELISA, Immunocytochemistry
• Conjugate: Unconjugated
• Regulatory Status: RUO
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
• Gene ID (Entrez): 7040
• Immunogen: Bovine bone-derived TGF-beta 1 and TGF-beta 2
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
• Test Specificity: Detects bovine, chicken, mouse, and human TGF-beta in ELISAs and Western blots. It recognizes human TGF-beta 1, TGF-beta 2, and TGF-beta 3. No cross-reactivity was observed with recombinant LAP in direct ELISAs.